Post Partum Hemorrhage
0
Pipeline Programs
3
Companies
3
Clinical Trials
1 recruiting
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
3 companies ranked by most advanced pipeline stage
One BiosciencesFrance - Paris
1 programEstablishment of a simulation lab and provision of simulation based trainingsN/A1 trial
Active Trials
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
One BiosciencesEstablishment of a simulation lab and provision of simulation based trainings
Novo NordiskEptacog alfa
Angel PharmaceuticalsThromboelastometry
Clinical Trials (3)
Total enrollment: 3,322 patients across 3 trials
NCT06577922One BiosciencesEstablishment of a simulation lab and provision of simulation based trainings
Evaluation of Maternal & Newborn Health Simulation Lab Centers of Excellence in Nepal
Start: May 2024Est. completion: Jul 2026
N/ARecruiting
NovoSeven® in Severe Postpartum Haemorrhage - Experiences From UK, DK, FR, NL
Start: May 2020Est. completion: Jan 20213,322 patients
N/ACompleted
Patient Blood Management for Massive Obstetric Hemorrhage
Start: Nov 2018Est. completion: Dec 2020
N/ACompleted
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
1 actively recruiting trials targeting 3,322 patients
3 companies competing in this space